Medtronic MiniMed, Inc.
Clinical trials sponsored by Medtronic MiniMed, Inc., explained in plain language.
Now part of
Medtronic plc
MDT
NYSE
Makes insulin pumps and diabetes management devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Implantable pump could ease diabetes management for 40 patients Results expected Dec 2026 (estimated)
- New insulin pump system put to the test in 400-Person safety trial Results expected Jan 2027 (estimated)
- New insulin pump system aims to improve diabetes management Results expected Mar 2027 (estimated)